Proteolytic processing of Stat6 signaling in mast cells as a negative regulatory mechanism

42Citations
Citations of this article
26Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Accumulating evidence has shown the importance of Stat6-mediated signaling in allergic diseases. In this study, we show a novel regulatory mechanism of Stat6-mediated signaling in mast cells. When Stat6 is activated by interleukin (IL)-4 and translocated to the nucleus, Stat6 is cleaved by a nucleus-associated protease in mast cells. The cleaved 65-kD Stat6 lacks the COOH-terminal transactivation domain and functions as a dominant-negative molecule to Stat6-mediated transcription. The retrovirus-mediated expression of cleavage-resistant Stat6 mutants prolongs the nuclear accumulation of Stat6 upon IL-4 stimulation and enhances IL-4-induced gene expression and growth inhibition in mast cells. These results indicate that the proteolytic processing of Stat6 functions as a lineage-specific negative regulator of Stat6-dependent signaling in mast cells, and thus suggest that it may account for the limited role of Stat6 in IL-4 signaling in mast cells.

Cite

CITATION STYLE

APA

Suzuki, K., Nakajima, H., Kagami, S. I., Suto, A., Ikeda, K., Hirose, K., … Iwamoto, I. (2002). Proteolytic processing of Stat6 signaling in mast cells as a negative regulatory mechanism. Journal of Experimental Medicine, 196(1), 27–38. https://doi.org/10.1084/jem.20011682

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free